The science test results has driven the whole of the share price movement.
52% of issued capital was traded in February and March on the back of the early announcements on the science released early February 18. It has gotten attention.
Given the first cohort took from 31 Aug 2017 to Feb 2018(5 months), Leslie indicated the second cohort should take about 3-4 months so end April early May for 2nd cohort seems reasonable.
Remember she stated admin/red tape from different counties held up first cohort testing not patient availability.
The country red tape wont hold up cohort test 2 or 3.
I reckon the next 90 days will be exciting and hold on to your hats when the next wave of announcements come through.
If you are as confident as Imugene in its science, I would imagine end of stage 2 will be the time a deal will be done unless someone offers something you cannot refuse.
Good luck to all shareholders.
Add to My Watchlist
What is My Watchlist?
